These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 7780646

  • 1. Role of endothelin-1 and the ETA receptor in the maintenance of deoxycorticosterone acetate-salt-induced hypertension.
    Fujita K, Matsumura Y, Kita S, Miyazaki Y, Hisaki K, Takaoka M, Morimoto S.
    Br J Pharmacol; 1995 Mar; 114(5):925-30. PubMed ID: 7780646
    [Abstract] [Full Text] [Related]

  • 2. ETA receptor-mediated role of endothelin in the kidney of DOCA-salt hypertensive rats.
    Fujita K, Matsumura Y, Miyazaki Y, Hashimoto N, Takaoka M, Morimoto S.
    Life Sci; 1996 Mar; 58(1):PL1-7. PubMed ID: 8628104
    [Abstract] [Full Text] [Related]

  • 3. Effects of the endothelin ETA-receptor antagonist FR139317 on development of hypertension and cardiovascular hypertrophy in deoxycorticosterone acetate-salt hypertensive rats.
    Fujita K, Matsumura Y, Miyazaki Y, Takaoka M, Morimoto S.
    Jpn J Pharmacol; 1996 Apr; 70(4):313-9. PubMed ID: 8774759
    [Abstract] [Full Text] [Related]

  • 4. Involvement of endothelin-1 in deoxycorticosterone acetate-salt-induced hypertension and cardiovascular hypertrophy.
    Matsumura Y, Fujita K, Miyazaki Y, Takaoka M, Morimoto S.
    J Cardiovasc Pharmacol; 1995 Apr; 26 Suppl 3():S456-8. PubMed ID: 8587444
    [Abstract] [Full Text] [Related]

  • 5. Endothelin ET(B) receptor-mediated action on systemic and renal hemodynamics and urine formation in deoxycorticosterone acetate-salt-induced hypertensive rats.
    Hashimoto N, Kuro T, Fujita K, Azuma S, Matsumura Y.
    Biol Pharm Bull; 1998 Aug; 21(8):800-4. PubMed ID: 9743245
    [Abstract] [Full Text] [Related]

  • 6. Ameliorating effect of an endothelin ETA receptor antagonist on renal function of DOCA-salt hypertensive rats.
    Matsumura Y, Hashimoto N, Fujita K, Morimoto S.
    Eur J Pharmacol; 1997 Jan 14; 319(1):65-9. PubMed ID: 9030899
    [Abstract] [Full Text] [Related]

  • 7. Endothelin-1 expression in blood vessels of DOCA-salt hypertensive rats treated with the combined ETA/ETB endothelin receptor antagonist bosentan.
    Larivière R, Sventek P, Thibault G, Schiffrin EL.
    Can J Physiol Pharmacol; 1995 Mar 14; 73(3):390-8. PubMed ID: 7544236
    [Abstract] [Full Text] [Related]

  • 8. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
    Li JS, Turgeon A, Schiffrin EL.
    Am J Hypertens; 1998 May 14; 11(5):554-62. PubMed ID: 9633791
    [Abstract] [Full Text] [Related]

  • 9. Direct measurements of endothelium-derived nitric oxide release by stimulation of endothelin receptors in rat kidney and its alteration in salt-induced hypertension.
    Hirata Y, Hayakawa H, Suzuki E, Kimura K, Kikuchi K, Nagano T, Hirobe M, Omata M.
    Circulation; 1995 Feb 15; 91(4):1229-35. PubMed ID: 7850963
    [Abstract] [Full Text] [Related]

  • 10. Role of endothelin-1 in hypertension induced by long-term inhibition of nitric oxide synthase.
    Fujita K, Matsumura Y, Miyazaki Y, Takaoka M, Morimoto S.
    Eur J Pharmacol; 1995 Jul 14; 280(3):311-6. PubMed ID: 8566099
    [Abstract] [Full Text] [Related]

  • 11. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
    Schiffrin EL, Turgeon A, Deng LY.
    Br J Pharmacol; 1997 Jul 14; 121(5):935-40. PubMed ID: 9222550
    [Abstract] [Full Text] [Related]

  • 12. Antihypertensive effect of an endothelin receptor antagonist in DOCA-salt spontaneously hypertensive rats.
    Schiffrin EL, Sventek P, Li JS, Turgeon A, Reudelhuber T.
    Br J Pharmacol; 1995 Aug 14; 115(8):1377-81. PubMed ID: 8564194
    [Abstract] [Full Text] [Related]

  • 13. Coronary vascular reactivity is improved by endothelin A receptor blockade in DOCA-salt hypertensive rats.
    Giulumian AD, Pollock DM, Clarke N, Fuchs LC.
    Am J Physiol; 1998 Jun 14; 274(6):R1613-8. PubMed ID: 9608015
    [Abstract] [Full Text] [Related]

  • 14. Endothelin receptor function in mesenteric veins from deoxycorticosterone acetate salt-hypertensive rats.
    Johnson RJ, Fink GD, Watts SW, Galligan JJ.
    J Hypertens; 2002 Apr 14; 20(4):665-76. PubMed ID: 11910302
    [Abstract] [Full Text] [Related]

  • 15. Role of endothelin and vasopressin in DOCA-salt hypertension.
    Yu M, Gopalakrishnan V, McNeill JR.
    Br J Pharmacol; 2001 Apr 14; 132(7):1447-54. PubMed ID: 11264238
    [Abstract] [Full Text] [Related]

  • 16. Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats.
    Matsumura Y, Hashimoto N, Taira S, Kuro T, Kitano R, Ohkita M, Opgenorth TJ, Takaoka M.
    Hypertension; 1999 Feb 14; 33(2):759-65. PubMed ID: 10024341
    [Abstract] [Full Text] [Related]

  • 17. Selective antagonism of endothelin ET(A) or ET(B) receptor in renal hemodynamics and function of deoxycorticosterone acetate-salt-induced hypertensive rats.
    Matsumura Y, Taira S, Kitano R, Hashimoto N, Kuro T.
    Biol Pharm Bull; 1999 Aug 14; 22(8):858-62. PubMed ID: 10480326
    [Abstract] [Full Text] [Related]

  • 18. Decreased endothelin binding and [Ca2+]i signaling in microvessels of DOCA-salt hypertensive rats.
    Molero MM, Giulumian AD, Reddy VB, Ludwig LM, Pollock JS, Pollock DM, Rusch NJ, Fuchs LC.
    J Hypertens; 2002 Sep 14; 20(9):1799-805. PubMed ID: 12195122
    [Abstract] [Full Text] [Related]

  • 19. Endothelin-1-induced venous contraction is maintained in DOCA-salt hypertension; studies with receptor agonists.
    Watts SW, Fink GD, Northcott CA, Galligan JJ.
    Br J Pharmacol; 2002 Sep 14; 137(1):69-79. PubMed ID: 12183332
    [Abstract] [Full Text] [Related]

  • 20. Enhanced expression of endothelin-1 gene may cause blood pressure-independent vascular hypertrophy.
    Schiffrin EL, Larivière R, Li JS, Sventek P, Touyz RM.
    J Cardiovasc Pharmacol; 1995 Sep 14; 26 Suppl 3():S5-8. PubMed ID: 8587458
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.